Discovery of widespread DNA damage in stem cell lines spurs call for pre-use sequencing
More than 70% of stem cell lines derived from human skin cells have damage to their DNA that could compromise their use in research and cell-based therapies, according to a study published August 11 in Nature Genetics. Read More
New technique could enable production of generic CAR T cells at scale
A Boston Children’s Hospital lab has developed a new method that could make chimeric antigen receptor (CAR) T-cell therapy more widely available using induced pluripotent stem cells to develop mature immune cells. Read More
NIH awards grants to launch experimental science rigor initiative
The National Institutes of Health (NIH) has awarded five new grants to launch an initiative designed to support education in the principles of rigorous scientific research. Read More
Thermo Fisher, Structura Biotechnology unveil particle analysis software
Thermo Fisher Scientific and Structura Biotechnology are partnering together on a new, single particle analysis software. The software will be a version of Structura's CryoSparc Live and will integrate with Thermo Fisher's Smart EPU software and cryo-transmission electron microscope technology. Read More
Video from AACC: Fluxergy's multimodal testing platform
Fluxergy president and co-founder Tej Patel sat down with us at AACC 2022 and discussed the company’s multimodal, multiomic platform that enables doctors to perform different kinds of tests, including reverse transcription polymerase chain reaction and serology tests, using a single instrument and software program. Read More
Video from AACC: Beckman Coulter partners with Scopio
Danaher’s Beckman Coulter Diagnostics has announced it has partnered with Scopio Labs to accelerate adoption of Scopio's next-generation peripheral blood smear platforms. Read More
Linus survey finds top two techniques or applications in life sciences R&D
A new survey of scientists finds that the top two techniques or applications in life sciences research and development (R&D) are CRISPR/cell-line engineering and artificial intelligence/machine learning-enabled bioinformatics when it comes to driving scientific advancements. Read More
Video from AACC: Cloud-connected point-of-care diagnostics
Lonnie Adelman, CEO and founder of iAssay, and Dean Wong, investor and advisor to the firm, talked to LabPulse.com (sister site of ScienceBoard.net) about the importance of cloud-connected point-of-care diagnostics, which enables the testing of people wherever they are and the conservation of data from testing.

Read More
Video from AACC: Reducing sequencing complexity
Clear Labs Chief Commercial Officer Jeff Field and Director of Assay Development Prasanna Thwar sat down with LabPulse.com (sister site of ScienceBoard.net) to discuss the launch of a platform that makes DNA sequencing easier by integrating robotic automation and cloud-based computing. Read More
Video from AACC: BrightInsight's Connected Diagnostics Platform
BrightInsight has launched the Connected Diagnostics Platform for the in vitro diagnostics manufacturer and the laboratory. The platform consists of four tools: Proxy Agent, Analytics Dashboards, Integration Middleware, and Workflow Portals. Read More
Conferences
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
International Society for Pharmaceutical Engineering Annual Meeting
October 30 - November 2
Orlando, Florida United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter